Raphael Pharmaceutical Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Dhadha Ajay Kumar | — | Award / Grant | 350,000 | — | — | 351,667 | Mar 5, 2025 |
| Pilo Shlomo | Chief Executive Officer | Award / Grant | 200,000 | $0.50 | $100,000 | 3,983,701 | Mar 2, 2025 |
| Eliya Yehuda | — | Award / Grant | 150,000 | $0.40 | $60,000 | 352,000 | Nov 25, 2023 |
| Louria Hayon Igal | Chief Technology Officer | X | 999,000 | $0.01 | $9,990 | 999,000 | Aug 29, 2023 |
| Press Joseph | — | Award / Grant | 280,000 | — | — | 280,000 | Jul 26, 2022 |
| Ofir Guy | Chief Financial Officer | Award / Grant | 1,000,000 | — | — | 1,266,455 | Jul 26, 2022 |
| Ofir Guy | President | Purchase | 286,000 | $0.06 | $17,160 | 3,875,800 | Oct 28, 2009 |
| Ofir Guy | President | Purchase | 404,153 | $0.10 | $40,415 | 20,724,153 | Sep 22, 2009 |
| Ofir Guy | President | Purchase | 100,000 | $0.07 | $7,000 | 20,320,000 | Dec 2, 2008 |
| Ofir Guy | President | Purchase | 15,000 | $0.08 | $1,200 | 20,120,000 | Nov 4, 2008 |
| Ofir Guy | President | Purchase | 5,000 | $0.14 | $700 | 3,510,000 | Oct 2, 2008 |
| Ofir Guy | President | Purchase | 38,500 | $0.15 | $5,775 | 3,568,500 | Sep 30, 2008 |
| Ofir Guy | President | Purchase | 20,000 | $0.15 | $3,000 | 3,520,000 | Sep 29, 2008 |
| Ofir Guy | President and Director | Purchase | — | — | — | 2,000,000 | Sep 29, 2008 |